CRISPR-related stocks sink after report that gene-editing technology might cause cancer

Shares of gene-therapy companies sank in active trade Monday, after a STAT report that editing a cell’s genome with CRISPR/Cas9 technology might cause cancer. CRISPR, or clustered regularly interspaced short palindromic repeats, is a gene-editing technique that uses the Cas9 enyzme to make precise changes to genes associated with specific diseases. The STAT report said…

Continue Reading →